Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily M Ko

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|March 28, 2021
Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumorsXiaoming Zhang, Kyle Devins, Emily M Ko, et al.
Gynecologic Oncology Reports|April 13, 2019
Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?Dimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Gynecologic Oncology Reports|March 21, 2023
Insurance and racial disparities in prior authorization in gynecologic oncologyAnna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, et al.
Gynecologic Oncology Reports|January 22, 2026
Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategiesMinyoung Jang, Stefan Gysler, Nawar A Latif, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 18, 2020
Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovaryDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2021
Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinomaDimitrios Nasioudis, Lakeisha Mulugeta-Gordon, Erin McMinn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 8, 2014
Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivorsJustin C Brown, Lilie L Lin, Saya Segal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinomaDimitrios Nasioudis, Orlando Arevalo, Stefan Gysler, et al.
Gynecologic Oncology|June 4, 2019
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinomaDimitrios Nasioudis, Ashley F Haggerty, Robert L Giuntoli, et al.
Gynecologic Oncology Reports|June 14, 2019
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumorsDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|March 28, 2021
Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumorsXiaoming Zhang, Kyle Devins, Emily M Ko, et al.
Gynecologic Oncology Reports|April 13, 2019
Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?Dimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Gynecologic Oncology Reports|March 21, 2023
Insurance and racial disparities in prior authorization in gynecologic oncologyAnna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, et al.
Gynecologic Oncology Reports|January 22, 2026
Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategiesMinyoung Jang, Stefan Gysler, Nawar A Latif, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 18, 2020
Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovaryDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2021
Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinomaDimitrios Nasioudis, Lakeisha Mulugeta-Gordon, Erin McMinn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 8, 2014
Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivorsJustin C Brown, Lilie L Lin, Saya Segal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinomaDimitrios Nasioudis, Orlando Arevalo, Stefan Gysler, et al.
Gynecologic Oncology|June 4, 2019
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinomaDimitrios Nasioudis, Ashley F Haggerty, Robert L Giuntoli, et al.
Gynecologic Oncology Reports|June 14, 2019
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumorsDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Pageof 13